# US 2013/0157349 A1 · Self-Contained Biological Analysis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157349 A1
- Document ID: US20130157349A1
- Status: Published application
- Kind: A1
- Application number: 13/765,249
- Filed: 2013-02-12
- Published: 2013-06-20
- Earliest claimed: 2005-05-09
- Assignees: BioFire Diagnostics, Inc. f/k/a Idaho Technology, Inc.
- Inventors: Kirk M. Ririe; Michael R. Newswander; Randy P. Rasmussen; Mark Aaron Poritz; Stewart Benjamin Smith; David E. Jones; Gary Clark Kessler
- Web page: https://patentgrep.com/patent/US20130157349A1

## CPC

- B01L 7/52: {with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples}
- B01L 3/50273: {characterised by the means or forces applied to move the fluids}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6844: Nucleic acid amplification reactions
- C12Q 1/686: Polymerase chain reaction [PCR]
- B01L 3/502723: {characterised by venting arrangements}
- B01L 2200/10: Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
- B01L 2300/0816: Cards, e.g. flat sample carriers usually with flow in two horizontal directions
- B01L 2300/0867: Multiple inlets and one sample wells, e.g. mixing, dilution
- B01L 2300/087: Multiple sequential chambers
- B01L 2300/123: Flexible; Elastomeric
- B01L 2300/1822: using Peltier elements
- B01L 2400/0478: pistons
- B01L 2400/0481: squeezing of channels or chambers
- B01L 2400/049: vacuum
- B01L 2400/0644: rotary valves
- B01L 2400/065: sliding valves
- B01L 2400/0655: pinch valves
- B01L 2400/0677: phase change valves; Meltable, freezing, dissolvable plugs; Destructible barriers
- B01L 2400/0683: mechanically breaking a wall or membrane within a channel or chamber
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Devices, containers, and methods are provided for performing biological analysis in a closed environment. Illustrative biological analyses include nucleic acid amplification and detection and immuno-PCR.

## Claims

### Claim 1

A container for performing two-stage nucleic acid amplification on a sample in a closed system comprising
one or more sealable ports, the sealable ports providing the only access from an exterior of the container such that when all of the one or more sealable ports is sealed, the container is fully closed, the one or more sealable ports including a sample injection port for introducing the sample into the container,
a cell lysis zone configured for lysing cells or spores located in the sample, the cell lysis zone fluidly connected to the sample injection port,
a nucleic acid preparation zone fluidly connected to the cell lysis zone, the nucleic acid preparation zone configured for purifying nucleic acids,
a first-stage reaction zone fluidly connected to the cell lysis zone, the first-stage reaction zone comprising a first-stage reaction blister configured for first-stage amplification of the sample, and
a second-stage reaction zone fluidly connected to the first-stage reaction zone, the second-stage reaction zone comprising a plurality of second-stage reaction chambers, each second-stage reaction chamber comprising a pair of primers configured for further amplification of the sample, the second-stage reaction zone configured for contemporaneous thermal cycling of all of the plurality of second-stage reaction chambers.

### Claim 2 (depends on 1)

The container of claim 1 wherein the first-stage amplification is multiplex amplification for a plurality targets, and each pair of primers in the second-stage reaction chambers is configured for further amplification of one of the first-stage targets.

### Claim 3 (depends on 2)

The container of claim 2 wherein each pair of primers in the second-stage reaction chamber is configured to be nested within primers used in amplifying the first-stage targets.

### Claim 4 (depends on 1)

The container of claim 1 wherein the one or more sealable ports further comprise a second port configured to receive water or reagents, and the sealable ports are configured to be sealed subsequent to introduction of the sample and water or reagents and remain sealed through first- and second-stage amplification.

### Claim 5 (depends on 1)

The container of claim 1 wherein the cell lysis zone comprises a cell lysis blister containing a plurality of lysing particles.

### Claim 6 (depends on 5)

The container of claim 5 wherein the particles are zirconium silicate beads.

### Claim 7 (depends on 6)

The container of claim 6 wherein the nucleic acid preparation zone comprises DNA-binding magnetic beads.

### Claim 8 (depends on 1)

The container of claim 1 wherein the blister comprises a flexible material, such that pressure provided on the blister collapses the blister, forcing the contents from the blister.

### Claim 9 (depends on 8)

The container of claim 8 wherein the flexible material is a flexible plastic film.

### Claim 10 (depends on 1)

The container of claim 1 wherein the second-stage reaction zone further comprises one or more additional second-stage reaction chambers, each of the additional second-stage reaction chambers configures as amplification controls.

### Claim 11 (depends on 1)

The container of claim 1 wherein the sealable ports are heat sealable.

### Claim 12 (depends on 1)

A device for analyzing a sample comprising
an opening for receiving the flexible container of claim 1, the flexible container further comprising
a first channel fluidly connecting the injection port to the cell lysis zone,
a second channel fluidly connecting the cell lysis zone to the nucleic acid preparation zone,
a third channel fluidly connecting the nucleic acid preparation zone to the first stage reaction zone, and
a fourth channel fluidly connecting the first stage reaction zone to the second-stage reaction zone,
a plurality of actuators, each of the plurality of actuators positioned corresponding to the zones and channels of the container, each actuator configured to apply pressure to the corresponding zone or channel, wherein sufficient pressure on one of the plurality of zones will force the sample from that zone, and wherein sufficient pressure on all channels connected to one of the plurality of zones will contain the sample within that zone,
a first heating/cooling device configured for thermal cycling contents of the first-stage reaction zone, and
a second heating/cooling device configured for thermal cycling contents of the second-stage reaction zone.

### Claim 13 (depends on 12)

The device of claim 12 further comprising optics mounted in the device and positioned to detect fluorescence from the plurality of second-stage reaction chambers.

### Claim 14 (depends on 12)

The device of claim 12 further comprising a magnet retractably positioned adjacent the nucleic acid preparation zone, and the nucleic acid amplification zone comprises DNA-binding magnetic beads

### Claim 15 (depends on 12)

The device of claim 12 further comprising a computer for controlling the actuators and the first and second heating/cooling devices.

### Claim 16 (depends on 12)

The device of claim 12 further comprising a seal bar for heat sealing the sealable ports.

### Claim 17

A container for performing two-stage nucleic acid amplification on a sample in a closed system comprising
one or more sealable ports, the sealable ports providing the only access from an exterior of the container such that when all of the one or more sealable ports is sealed, the container is fully closed, the one or more sealable ports including a sample injection port for introducing the sample into the container,
a first-stage reaction zone fluidly connected to the sample injection port, the first-stage reaction zone comprising a first-stage reaction blister configured for first-stage amplification of the sample, and
a second-stage reaction zone fluidly connected to the first-stage reaction zone, the second-stage reaction zone comprising a plurality of second-stage reaction chambers, each second-stage reaction chamber comprising a pair of primers configured for further amplification of the sample, the second-stage reaction zone configured for contemporaneous thermal cycling of all of the plurality of second-stage reaction chambers.

### Claim 18 (depends on 17)

The container of claim 17 further comprising
a cell lysis zone configured for lysing cells or spores located in the sample,
a nucleic acid preparation zone fluidly connected to the cell lysis zone, the nucleic acid preparation zone configured for purifying nucleic acids.
the cell lysis zone and the nucleic acid preparation zone both fluidly located between the sample injection port and the first-stage reaction zone.
